Brain Protection after Anoxic Brain Injury: Is Lactate Supplementation Helpful?


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
06 07 2021
Historique:
received: 08 06 2021
revised: 02 07 2021
accepted: 05 07 2021
entrez: 7 8 2021
pubmed: 8 8 2021
medline: 29 10 2021
Statut: epublish

Résumé

While sudden loss of perfusion is responsible for ischemia, failure to supply the required amount of oxygen to the tissues is defined as hypoxia. Among several pathological conditions that can impair brain perfusion and oxygenation, cardiocirculatory arrest is characterized by a complete loss of perfusion to the brain, determining a whole brain ischemic-anoxic injury. Differently from other threatening situations of reduced cerebral perfusion, i.e., caused by increased intracranial pressure or circulatory shock, resuscitated patients after a cardiac arrest experience a sudden restoration of cerebral blood flow and are exposed to a massive reperfusion injury, which could significantly alter cellular metabolism. Current evidence suggests that cell populations in the central nervous system might use alternative metabolic pathways to glucose and that neurons may rely on a lactate-centered metabolism. Indeed, lactate does not require adenosine triphosphate (ATP) to be oxidated and it could therefore serve as an alternative substrate in condition of depleted energy reserves, i.e., reperfusion injury, even in presence of adequate tissue oxygen delivery. Lactate enriched solutions were studied in recent years in healthy subjects, acute heart failure, and severe traumatic brain injured patients, showing possible benefits that extend beyond the role as alternative energetic substrates. In this manuscript, we addressed some key aspects of the cellular metabolic derangements occurring after cerebral ischemia-reperfusion injury and examined the possible rationale for the administration of lactate enriched solutions in resuscitated patients after cardiac arrest.

Identifiants

pubmed: 34359883
pii: cells10071714
doi: 10.3390/cells10071714
pmc: PMC8305209
pii:
doi:

Substances chimiques

Hypertonic Solutions 0
Neuroprotective Agents 0
Lactic Acid 33X04XA5AT

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Fonds Erasme pour la recherche médicale
ID : bouse Chloé

Déclaration de conflit d'intérêts

All authors declare not to have any conflict of interest regarding the manuscript.

Références

Crit Care. 2020 Jun 16;24(1):354
pubmed: 32546181
eNeuro. 2018 Jan 23;4(6):
pubmed: 29379872
J Neurosci Res. 2017 Nov;95(11):2103-2125
pubmed: 28151548
J Cereb Blood Flow Metab. 1995 Jul;15(4):587-94
pubmed: 7540620
J Clin Neurophysiol. 2016 Jun;33(3):203-10
pubmed: 27258443
Neurosurg Focus. 2007 May 15;22(5):E2
pubmed: 17613233
Am J Physiol Cell Physiol. 2002 May;282(5):C1136-46
pubmed: 11940529
Resuscitation. 2020 Mar 1;148:218-226
pubmed: 32027980
Intensive Care Med. 2014 Jun;40(6):920-1
pubmed: 24789621
Stroke. 2001 Jan;32(1):128-32
pubmed: 11136927
J Trauma. 1994 Dec;37(6):899-908
pubmed: 7996602
Neurosci Lett. 1999 Sep 17;272(3):195-8
pubmed: 10505614
Clin Sci (Lond). 1998 Feb;94(2):157-63
pubmed: 9536924
Cell. 2015 Apr 23;161(3):610-621
pubmed: 25910210
Arch Neurol. 1989 Jan;46(1):93-7
pubmed: 2910267
Cardiology. 2013;125(2):92-3
pubmed: 23711672
Proc Natl Acad Sci U S A. 2014 Sep 9;111(36):13010-5
pubmed: 25157149
Intensive Care Med. 2014 Jun;40(6):919
pubmed: 24789617
J Cereb Blood Flow Metab. 2009 Nov;29(11):1780-9
pubmed: 19675565
Crit Care Med. 2005 Dec;33(12 Suppl):S530-4
pubmed: 16340442
Brain Res. 2000 Apr 10;861(2):281-7
pubmed: 10760489
Crit Care Med. 2018 Oct;46(10):1649-1655
pubmed: 29923931
Intensive Care Med. 2013 Nov;39(11):1972-80
pubmed: 23942856
J Cereb Blood Flow Metab. 2009 Jun;29(6):1121-9
pubmed: 19337275
Resuscitation. 2019 Jan;134:26-32
pubmed: 30562596
Shock. 2016 Dec;46(6):663-671
pubmed: 27392154
J Neurochem. 2003 Dec;87(6):1381-90
pubmed: 14713294
Neurohospitalist. 2014 Jul;4(3):153-63
pubmed: 24982721
Crit Care Med. 1986 Jul;14(7):634-7
pubmed: 3087700
Neurochem Int. 2013 Feb;62(3):251-7
pubmed: 23298645
J Cereb Blood Flow Metab. 2012 Jul;32(7):1152-66
pubmed: 22027938
J Clin Invest. 1948 Jul;27(4):476-83
pubmed: 16695568
Resuscitation. 2002 Jul;54(1):47-55
pubmed: 12104108
Resuscitation. 2019 Aug;141:96-103
pubmed: 31185256
Crit Care. 2014 Mar 25;18(2):R48
pubmed: 24666826
Lancet. 1994 Jan 1;343(8888):16-20
pubmed: 7905041
Crit Care Resusc. 2018 Jun;20(2):124-130
pubmed: 29852851
Best Pract Res Clin Anaesthesiol. 2015 Dec;29(4):451-64
pubmed: 26670816
J Neurotrauma. 2016 Apr 1;33(7):681-7
pubmed: 26421521
Nat Rev Neurosci. 2018 Apr;19(4):235-249
pubmed: 29515192
J Neurobiol. 1981 May;12(3):211-20
pubmed: 7276923
Resuscitation. 2021 Apr;161:61-79
pubmed: 33773833
Intensive Care Med. 2014 Mar;40(3):412-21
pubmed: 24477453
Intensive Care Med. 2013 Aug;39(8):1413-22
pubmed: 23749153
Prog Neurobiol. 2001 Apr;63(6):687-96
pubmed: 11165001
Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10625-9
pubmed: 7938003
Resuscitation. 2004 Oct;63(1):73-83
pubmed: 15451589
PLoS One. 2014 May 06;9(5):e96585
pubmed: 24802253
J Neurochem. 2009 May;109 Suppl 1:55-62
pubmed: 19393009
Lancet. 2008 Jun 7;371(9628):1955-69
pubmed: 18539227
Physiol Rev. 1997 Jul;77(3):731-58
pubmed: 9234964
Lancet Neurol. 2007 Mar;6(3):258-68
pubmed: 17303532
Front Cell Neurosci. 2020 Mar 19;14:51
pubmed: 32265656
Chest. 2002 Aug;122(2):699-711
pubmed: 12171853
J Neurol Sci. 2012 Apr 15;315(1-2):1-8
pubmed: 22251931
Front Neurosci. 2017 Feb 02;11:43
pubmed: 28210209
Cerebrovasc Dis. 2012;34(5-6):329-35
pubmed: 23154656
Resuscitation. 2020 Jul;152:39-49
pubmed: 32272235
Physiol Rev. 2019 Jan 1;99(1):949-1045
pubmed: 30565508
J Clin Med Res. 2016 Apr;8(4):277-83
pubmed: 26985247
Brain Res. 2002 Feb 22;928(1-2):156-9
pubmed: 11844482
NeuroRehabilitation. 2010;26(1):5-13
pubmed: 20130351
Intensive Care Med. 2009 Mar;35(3):471-9
pubmed: 18807008
JAMA. 2019 Mar 26;321(12):1200-1210
pubmed: 30912843
J Neurosci Res. 2001 Dec 1;66(5):790-4
pubmed: 11746403

Auteurs

Filippo Annoni (F)

Department of Intensive Care, Erasme Hospital, Free University of Brussels, Route de Lennik 808, 1070 Anderlecht, Belgium.
Laboratory of Acute Brain Injury and Therapeutic Strategies, Department of Neuroscience, Mario Negri Institute for Pharmacological Research IRCCS, Via Mario Negri 2, 20156 Milan, Italy.

Lorenzo Peluso (L)

Department of Intensive Care, Erasme Hospital, Free University of Brussels, Route de Lennik 808, 1070 Anderlecht, Belgium.

Elisa Gouvêa Bogossian (E)

Department of Intensive Care, Erasme Hospital, Free University of Brussels, Route de Lennik 808, 1070 Anderlecht, Belgium.

Jacques Creteur (J)

Department of Intensive Care, Erasme Hospital, Free University of Brussels, Route de Lennik 808, 1070 Anderlecht, Belgium.

Elisa R Zanier (ER)

Laboratory of Acute Brain Injury and Therapeutic Strategies, Department of Neuroscience, Mario Negri Institute for Pharmacological Research IRCCS, Via Mario Negri 2, 20156 Milan, Italy.

Fabio Silvio Taccone (FS)

Department of Intensive Care, Erasme Hospital, Free University of Brussels, Route de Lennik 808, 1070 Anderlecht, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH